KIR3DL1 Antibody (MM0443-1L34) [Janelia Fluor® 549]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-11763JF549
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Block/Neutralize, CyTOF-ready, Flow Cytometry
Label
Janelia Fluor 549
Antibody Source
Monoclonal Mouse IgG1 Clone # MM0443-1L34
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Human recombinant KIR3DL1
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for KIR3DL1 Antibody (MM0443-1L34) [Janelia Fluor® 549]
Application
Recommended Usage
Block/Neutralize
Optimal dilutions of this antibody should be experimentally determined.
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KIR3DL1
Long Name
Killer Cell Immunoglobulin-like Receptor, Three Domain Long Cytoplasmic Tail, 1
Alternate Names
CD158e1, Nkat3, NKB1
Gene Symbol
KIR3DL1
Additional KIR3DL1 Products
Product Documents for KIR3DL1 Antibody (MM0443-1L34) [Janelia Fluor® 549]
Product Specific Notices for KIR3DL1 Antibody (MM0443-1L34) [Janelia Fluor® 549]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...